Work for Phio Pharmaceuticals Corp.?

Claim Your Profile

Phio Pharmaceuticals Corp. Logo Image

Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp. Banner Image

About Phio Pharmaceuticals Corp.

11-50 Employees
Based in Marlborough, Massachusetts

Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYLâ„¢) therapeutic platform. The Company's efforts are focused on silencing tumor-induced suppression of the immune system through its proprietary INTASYL platform with utility in immune cells and the tumor micro-environment. Their goal is to develop powerful INTASYL therapeutic compounds that can weaponize immune effector cells to overcome tumor immune escape, thereby providing patients a powerful new treatment option that goes beyond current treatment modalities.

Ticker:
PHIO
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol